HilleVax Ownership | Who Owns HilleVax?

Overview Forecast RevenueFinancials Chart

HilleVax Ownership Summary

HilleVax is owned by 70.92% institutional investors, 17.11% insiders, and 11.97% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 21.91% of HLVX shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.54% of its assets in HilleVax shares.

HLVX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	HilleVax	70.92%	17.11%	11.97%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Frazier life sciences management	10.62M	21.91%	$153.52M
Deerfield management company, l.p. (series c)	4.00M	8.26%	$57.90M
Blackrock	2.09M	4.31%	$30.23M
Franklin resources	1.99M	4.10%	$28.75M
Carlyle group	1.84M	3.79%	$26.44M
Vanguard group	1.40M	2.90%	$20.30M
Catalys pacific	1.21M	2.49%	$17.48M
Stepstone group lp	826.57K	1.71%	$11.95M
Samsara biocapital	799.27K	1.65%	$11.56M
Geode capital management	708.03K	1.46%	$10.24M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Qiming u.s. ventures management	558.92K	15.36%	$8.08M
Catalys pacific	1.21M	13.19%	$17.48M
Frazier life sciences management	10.62M	7.18%	$153.52M
Carlyle group	1.84M	2.51%	$26.44M
Stepstone group lp	826.57K	2.42%	$11.95M
Samsara biocapital	799.27K	2.42%	$11.56M
Deerfield management company, l.p. (series c)	4.00M	0.96%	$57.90M
Virtus etf advisers	6.12K	0.04%	$88.45K
Ubs oconnor	46.97K	0.04%	$679.19K
Franklin resources	1.99M	0.01%	$28.75M

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	10.62M	7.18%	835.59K
Blackrock	2.09M	0.00%	290.33K
Franklin resources	1.99M	0.01%	133.53K
State street	595.45K	0.00%	106.71K
Nuveen asset management	137.71K	0.00%	89.30K

Top Sellers

Holder	Shares	% Assets	Change
T. rowe price investment management	-	-	-3.48M
Vr adviser	-	-	-2.08M
Deep track capital, lp	-	-	-1.83M
Janus henderson group	-	-	-1.12M
Bioimpact capital	-	-	-645.09K

New Positions

Holder	Shares	% Assets	Change	Value
Alps advisors	38.79K	0.00%	38.79K	$560.86K
Corebridge financial	16.96K	0.00%	16.96K	$245.18K
Two sigma advisers, lp	16.10K	0.00%	16.10K	$232.81K
Mirae asset global etfs	13.02K	0.00%	13.02K	$188.21K
Price t rowe associates inc /md/	10.06K	-	10.06K	$146.00K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-4.00
Rothschild investment	-10.00
Quarry lp	-61.00
Quest partners	-832.00
Metropolitan life insurance co/ny	-1.56K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	78	-13.33%	35,023,214	-9.66%	70	1.11%	49	-24.62%	18	50.00%
Jun 30, 2024	90	13.92%	38,767,553	4.27%	79	1.31%	65	62.50%	12	-47.83%
Mar 31, 2024	79	16.18%	37,178,279	4.62%	78	0.94%	40	-11.11%	23	91.67%
Dec 31, 2023	68	-	35,536,488	4.11%	91	1.13%	45	-6.25%	12	33.33%
Sep 30, 2023	68	25.93%	34,134,471	34.36%	89	1.99%	48	41.18%	9	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin Biotechnology Discv A(acc)USD	1.26M	2.54%	-
iShares Russell 2000 ETF	807.94K	1.63%	-1.82K
T. Rowe Price US Small-Cap Core Equity	806.64K	1.62%	173.56K
Vanguard Total Stock Mkt Idx Inv	736.13K	1.49%	-
Franklin Biotechnology Discovery A	691.36K	1.39%	-
T. Rowe Price U.S. SC Value Eq Tr-Z	439.91K	0.88%	3.33K
T. Rowe Price U.S. SC Core Eq Tr-Z	394.48K	0.79%	89.26K
Vanguard Institutional Extnd Mkt Idx Tr	387.79K	0.78%	-
Fidelity Small Cap Index	313.03K	0.63%	-14.45K
Xtrackers S&P 500 Swap ETF 1C	298.90K	0.60%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 20, 2024	Kohli Aditya	-	Sell	$92.69K
May 22, 2024	Kohli Aditya	-	Sell	$88.37K
May 21, 2024	Kohli Aditya	-	Sell	$85.23K
May 02, 2024	Kohli Aditya	-	Sell	$84.08K
May 01, 2024	Kohli Aditya	-	Sell	$2.46K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	1	9
2024 Q1	1	14
2023 Q4	-	5
2023 Q2	-	-
2023 Q1	-	-

HLVX Ownership FAQ

Who Owns HilleVax?

HilleVax shareholders are primarily institutional investors at 70.92%, followed by 17.11% insiders and 11.97% retail investors. The average institutional ownership in HilleVax's industry, Biotech Stocks , is 44.97%, which HilleVax exceeds.

Who owns the most shares of HilleVax?

HilleVax’s largest shareholders are Frazier life sciences management (10.62M shares, 21.91%), Deerfield management company, l.p. (series c) (4M shares, 8.26%), and Blackrock (2.09M shares, 4.31%). Together, they hold 34.49% of HilleVax’s total shares outstanding.

Does Blackrock own HilleVax?

Yes, BlackRock owns 4.31% of HilleVax, totaling 2.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.23M$. In the last quarter, BlackRock increased its holdings by 290.33K shares, a 16.13% change.

Who is HilleVax’s biggest shareholder by percentage of total assets invested?

Qiming u.s. ventures management is HilleVax’s biggest shareholder by percentage of total assets invested, with 15.36% of its assets in 558.92K HilleVax shares, valued at 8.08M$.

Who is the top mutual fund holder of HilleVax shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of HilleVax shares, with 2.54% of its total shares outstanding invested in 1.26M HilleVax shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools